We read with great interest the paper entitled "No association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis" published in Tumor Biol. The cumulative meta-analysis showed that the results maintained the same, while the ORs with 95 % CI were more stable with the accumulation of case-control studies. It is a valuable study.
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Nevertheless, careful examination of the data provided by Zhang et al. [1] (shown in Table 1 in their original text) revealed two key issues that are worth noticing. Firstly, one overlapping paper [2] was not properly excluded from Zhang et al.'s study [1] . Secondly, the data reported by Zhang et al. [1] for the study by Wang et al. [3] do not seem in line with the data provided by Wang et al. [3] in their original publication. The numbers reported by Wang et al. [3] (shown in Table 1 in Wang et al.'s original paper) for Arg/Arg, Arg/Trp, and Trp/Trp, in cases and controls, are 89, 80, and 40 and 138, 90, and 28, respectively. Interestingly enough, after carefully examining the data reported by Zhang et al. [1] , the numbers are 105, 83, and 21 in cases and 137, 96, and 23 in controls, respectively (supporting information). Therefore, the conclusions by Zhang et al. [1] are not entirely reliable. It is required to clarify the association between XRCC1 Arg194Trp polymorphism and lung cancer risk. We reassessed this association by performing a metaanalysis on the basis of a total of 30 studies with 9508 cases and 11,845 controls, which may provide comprehensive evidence for the association of XRCC1 Arg194Trp polymorphism with lung cancer risk. Table 1 listed the general information of selected studies. (Fig. 1b, c) . The cumulative meta-analysis accumulated the studies in the light of publication year and showed that there was still a significant association between XRCC1 codon 194 Trp/Trp polymorphism and lung cancer risk, the cumulative odds ratio was 1.26 with 95 %CI: 1.09-1.45 (Fig. 2) . Limiting the analysis to the studies with controls in agreement with Hardy-Weinberg equilibrium (HWE), we observed an increased risk of lung cancer among subjects carrying Trp/Trp genotype, compared with Arg/Arg genotype (OR = 1.17, 95 %CI: 1.01-1.36) ( (Table 2) . We did not observe any association between XRCC1 Arg194Trp polymorphism and lung cancer risk in additional subgroup analyses ( Table 2 ).
The shape of funnel plots seemed to be approximately symmetrical (Fig. 3a-c) . Both Egger's test and Begg's test results suggested no evidence of publication biases existed in this meta-analysis (Table 2) .
Sensitivity analysis was performed to evaluate the root of heterogeneity. The combined estimates were not altered when the studies were lack of heterogeneity for Arg/Trp vs. Arg/Arg and Trp/Trp+Arg/Trp vs. Arg/ Arg polymorphisms among total population by deleting Song et al.'s study [4] , Du et al.'s study [5] , and Buch et al.'s study [6] (data not shown). 
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